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likely because they increased ac-
cess to poor-quality care. What 
can India do to demonstrate its 
commitment to quality? Invest-
ments in collecting data in elec-
tronic records that systematically 
measure quality are part of the 
solution, but we believe that a 
national program that defines 
and tracks quality across the 
spectrum of care is crucial. Be-
yond the health benefits of im-
proving quality, such programs 
build trust, encouraging people 
to return. Without deliberate at-
tention to and action on quality, 
it’s unlikely that the reform will 
lead to better health outcomes.
The Indian health insurance 
scheme will be studied closely. 
Five Indian states are opting out 
of the reform; the reach and suc-
cess of Ayushman Bharat will be 
determined in part by the ability 
of these states to effectively dem-
onstrate that their models are ex-
panding access, providing finan-
cial protection, and improving 
health outcomes. Parts of India 
have health indicators compara-
ble to those of southern Europe, 
while other areas mirror parts of 
sub-Saharan Africa. No single 
strategy will work, but India’s di-
verse landscape also means that 
an extraordinary learning oppor-
tunity for implementing univer-
sal health coverage on a vast scale 
is unfolding. If the government 
invests heavily in evaluations, test-
ing new approaches, and listening 
intently to states, it can ensure 
that relevant lessons are learned.
India’s bold step toward reform 
reflects an increasingly intercon-
nected world and the desire of all 
people to have access to the 
fruits of modern medicine. From 
Mexico in 2006, to the United 
States in 2010, to China in 2016, 
to India now, universal coverage 
has become reform’s rallying cry. 
A high-profile failure, however, 
will set this movement back. India 
has the formula to succeed, and 
we believe the emphases outlined 
here can help India show the 
world that health care for all is 
eminently possible, even in the 
most complex of circumstances.
Disclosure forms provided by the authors 
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The Hospital Readmissions Re-duction Program (HRRP) was 
established by the Centers for 
Medicare and Medicaid Services 
(CMS) in 2010 with a goal of 
 reducing preventable hospitaliza-
tions by imposing financial pen-
alties on hospitals with higher-
than-expected 30-day readmission 
rates. After the program was cre-
ated, readmission rates appeared 
to decrease nationwide for patients 
hospitalized with heart failure, 
acute myocardial infarction, and 
pneumonia, the three conditions 
it originally targeted.
Some policymakers have pushed 
for the HRRP to be expanded to 
cover all conditions treated in 
inpatient settings. Others, includ-
ing many clinicians and research-
ers, have expressed skepticism 
regarding the program’s effects 
and concerns about unintended 
consequences. These concerns 
stem from three major limitations 
of the program.
First, the HRRP defines only 
inpatient hospitalizations — not 
observation stays or emergency 
department (ED) visits — as re-
admissions, which has artificially 
inflated estimates of its success. 
Although readmission rates have 
decreased for targeted conditions, 
rates of observation stays and ED 
visits after inpatient stays have 
increased; as a result, the pro-
portion of patients who return to 
a hospital within 30 days after 
discharge has not changed. This 
blind spot also creates strong in-
centives to treat patients in EDs 
or observation units to avoid re-
admissions, even if inpatient hos-
pitalization would improve their 
access to appropriate care. The 
HRRP also doesn’t include ob-
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servation stays as index events, 
so little is known about postdis-
charge outcomes for patients ad-
mitted under observation status. 
Since hospitals vary widely in 
their use of observation units, 
excluding these stays may create 
an uneven playing field for com-
paring hospital performance.
A second limitation is that the 
HRRP metric doesn’t account for 
the competing risk of death. A pa-
tient who dies can no longer be 
readmitted. But because deaths 
aren’t factored into readmission 
rates, hospitals that keep more 
patients alive and therefore dis-
charge a sicker group of people 
may be penalized for having high-
er readmission rates rather than 
rewarded for having good out-
comes. This problem is exacer-
bated by the fact that penalties 
for high readmission rates under 
the HRRP are much larger than 
penalties for high mortality un-
der the Hospital Value-Based Pur-
chasing program.
Third, risk adjustment of the 
readmission measure is inade-
quate, which encumbers fair com-
parisons among hospitals. Re-
admission models are notoriously 
poor at predicting events. Although 
coexisting conditions such as dia-
betes are well captured in risk-
adjustment models, factors such 
as functional status and frailty, 
which meaningfully improve risk 
prediction, are not. Health care 
utilization patterns are also not 
accounted for in current models. 
As a result, differences in severity 
of illness between a person with 
heart failure who has one brief 
hospitalization for swollen ankles 
and another who is repeatedly 
hospitalized for decompensated 
heart failure are poorly captured. 
Because of their relative simplic-
ity, current models are also easy 
to “game.” Growing evidence sug-
gests that much of the reported 
improvement in risk-adjusted re-
admission rates that drove early 
enthusiasm for the program may 
have been the result of an artifi-
cial increase in coded coexisting 
conditions rather than improve-
ments in care quality.
Current risk-adjustment mod-
els also omit social risk factors 
that are strongly related to re-
admissions, such as poverty, so 
hospitals tend to be penalized 
for serving poor and vulnerable 
patients. Safety-net hospitals are 
frequently penalized under the 
HRRP, which results in a transfer 
of resources away from resource-
poor sites. The 21st Century 
Cures Act implemented a stratifi-
cation scheme in the HRRP this 
year such that hospitals are com-
pared only with other facilities 
that treat Medicare populations 
with similar poverty levels. This 
change was associated with a sig-
nificant reduction in penalties for 
safety-net hospitals.
Finally, mounting evidence sug-
gests that the HRRP may have 
had unintended consequences, 
particularly for patients with heart 
failure. Four independent studies 
revealed that mortality within 30 
days after discharge from a hos-
pitalization for heart failure in-
creased significantly after imple-
mentation of the HRRP relative 
to earlier trends.1-4 This increase 
was concentrated among patients 
who weren’t readmitted, which 
raises the possibility that greater 
use of EDs and observation units 
by hospitals to reduce readmis-
sions may adversely affect patients 
who would benefit from higher-
level care.
Two studies have come to dif-
ferent conclusions, however. One 
investigation, by the group that 
developed the readmission mea-
sure, found that although 30-day 
postdischarge mortality among 
patients with heart failure in-
creased after the HRRP was en-
acted, changes from previous 
trends were not statistically sig-
nificant.5 A report by the Medicare 
Payment Advisory Commission 
showed that raw in-hospital-
through-postdischarge mortality 
among patients with heart fail-
ure increased between 2008 and 
2016, but risk-adjusted mortality 
decreased — from 13.6% to 9.4%. 
In contrast, studies have consis-
tently found that mortality among 
patients hospitalized for myocar-
dial infarction has not increased 
under the HRRP,1,5 which sug-
gests that acute conditions may 
be better suited to the program 
than chronic conditions such as 
heart failure.
How can we strengthen the 
HRRP to mitigate potential un-
intended consequences and ensure 
that the program improves care 
quality and patient outcomes?
Rather than using only inpa-
tient readmission rates to evalu-
ate hospital performance, the 
HRRP could use a “return-to-
hospital” metric that also in-
cludes rates of ED visits and ob-
servation-unit stays within 30 days 
after discharge. These outcomes 
wouldn’t have to be weighted 
equally. Such a measure would 
strengthen hospitals’ incentive to 
focus on improving care transi-
tions and postdischarge care to 
reduce unnecessary returns to the 
hospital. It would also encourage 
hospitals to make more consid-
ered care decisions for patients 
who do return and permit a fairer 
assessment of hospitals’ perfor-
mance. Furthermore, treating both 
inpatient and observation-unit 
stays as index events could pro-
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vide a more comprehensive pic-
ture of hospital-based encounters 
after discharge.
In addition, we believe the 
metric used in the HRRP should 
account for the competing risk 
of death, both during and after 
hospitalization. One potential ap-
proach would be to evaluate per-
formance during the period pa-
tients are alive within 30 days 
after discharge. Another possibil-
ity would be to create a joint out-
come measure that combines hos-
pital returns and deaths within 
30 days. CMS could also ensure 
that financial incentives to reduce 
mortality are greater than incen-
tives to reduce readmissions.
The HRRP’s risk-adjustment 
methods could also be improved. 
The evidence that social risk fac-
tors influence readmission rates is 
incontrovertible. Directly adjust-
ing for dual-enrollment status 
(coverage under both Medicare 
and Medicaid) in risk models 
would allow all hospitals to re-
ceive similar “credit” for caring 
for vulnerable patients. Although 
dual status is a somewhat limit-
ed measure of social risk, a grow-
ing body of evidence suggests 
that adding more detailed social-
risk data adds little to risk pre-
diction. On the other hand, adding 
covariates such as prior hospital 
utilization, functional status, and 
frailty meaningfully improves risk 
models, particularly for poor and 
disabled populations. By focus-
ing on more holistic risk adjust-
ment, such changes might also 
make the metric less gameable.
In the long run, CMS could 
consider using revenue generat-
ed from the HRRP to assist 
 resource-poor hospitals that con-
sistently have high readmission 
rates in improving discharge plan-
ning or care coordination ser-
vices. Since many factors that 
drive readmissions act outside 
hospital walls, assistance might 
be most valuable if used to im-
prove postdischarge primary and 
specialty care, address social de-
terminants of health, and create 
linkages between hospitals and 
community partners. Pairing pen-
alties with resources to encour-
age implementation of innovative 
programs focused on resource-
poor settings could help ensure 
that the HRRP’s net effect is pos-
itive.
More broadly, the ongoing de-
bate about the HRRP underscores 
the consequences of implement-
ing national policies with no con-
trol group and no plan for itera-
tive improvement. For this reason, 
we believe any change to the 
HRRP should be made in the 
context of a robust evaluation 
effort to determine its effect on 
patient experience, care quality, 
and outcomes. Throughout the 
process, we believe it is impera-
tive that policymakers seek input 
from frontline clinicians and pa-
tients who understand the real-
world effects of this program. 
Together, these improvements 
could reboot the HRRP and trans-
form it from a regressive penalty 
program to a progressive pro-
gram that improves patient care.
Disclosure forms provided by the authors 
are available at NEJM.org.
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